©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: FDA
Cannabis and Coronavirus: Politics, Pandemic Continue to Plague Economy
Though infection rates are slowing, the United States has added an average of 1,000 COVID-19 deaths daily, for the last sixteen days. In regional...
Massachusetts Releases Thousands of Quarantined Vape Products
WORCESTER, Mass. – The Massachusetts Cannabis Control Commission (CCC) this week announced it will release vape products that had been quarantined by the state...
FDA Approves Epidiolex to Treat Tuberous Sclerosis Seizures
CARLSBAD, Calif. – Greenwich Biosciences, Inc. and its parent company GW Pharmaceuticals, a British company involved in the development and manufacturing of plant-derived cannabinoid...
FDA Releases Guidelines on Research Related to Cannabis-Derived Compounds
WASHINGTON, D.C. – The Food and Drug Administration (FDA) this week released draft guidelines for the creation of cannabis research regulations. The guidance titled...
DOT Cautions Commercial Drivers: No Leeway for ‘Innocent Ingestion’ of THC
WASHINGTON, D.C. – As the hemp industry matures, cannabidiol products such as oils and massage creams continue to gain mainstream success specifically because they...
Is CBD on the Cusp of FDA Approval?
Don’t believe everything you read. Despite the widespread misinformation campaign that cannabidiol (CBD), which is believed to provide medical benefits, is fully legal, that...
Cannabis and Coronavirus: The New Normal-ish
Uncertainty created by economic backlash from the coronavirus pandemic has global markets shaken, even as U.S. stock markets have rallied to pre-pandemic levels, defying...
Product Recall Issued for CBD Oil Due to Lead Contamination
WASHINGTON, D.C. – A batch of CBD oil has been voluntarily recalled by its manufacturer after testing positive for higher than acceptable levels of...
Key DEA Change Could Make Cannabis-Based Medicine More Accessible
Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.
Epidiolex, produced by...
Cannabis and Coronavirus: New Frontier Webinar Focuses on Risk, Opportunity
Cannabis marketing data firm New Frontier Data yesterday hosted a day-long webinar on the effect of the coronavirus (COVID-19) crisis on the global cannabis...